bucladesine and cyclosporin d

bucladesine has been researched along with cyclosporin d in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grünbaum, L; Seifert, R; Wenzel-Seifert, K	1

Other Studies

1 other study(ies) available for bucladesine and cyclosporin d

Article	Year
Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation. Journal of immunology (Baltimore, Md. : 1950), 1991, Sep-15, Volume: 147, Issue:6 Topics: Bucladesine; Calcium; Cell Aggregation; Cell Differentiation; Complement C5a; Cyclosporine; Cyclosporins; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Glucuronidase; Humans; In Vitro Techniques; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Formyl Peptide; Receptors, Immunologic; Superoxides; Time Factors; Tumor Cells, Cultured	1991

Article

Year

Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.

Journal of immunology (Baltimore, Md. : 1950), 1991, Sep-15, Volume: 147, Issue:6

Topics: Bucladesine; Calcium; Cell Aggregation; Cell Differentiation; Complement C5a; Cyclosporine; Cyclosporins; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Glucuronidase; Humans; In Vitro Techniques; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Formyl Peptide; Receptors, Immunologic; Superoxides; Time Factors; Tumor Cells, Cultured

1991